A detailed history of Cloud Capital Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cloud Capital Management, LLC holds 1 shares of SUPN stock, worth $45. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$45
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$31.45 - $47.79 $31 - $47
1 New
1 $0

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Cloud Capital Management, LLC Portfolio

Follow Cloud Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Capital Management, LLC with notifications on news.